-
Notifications
You must be signed in to change notification settings - Fork 0
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
Merge pull request #12 from conorheffron/readme-doc-up
Update ReadMe.md
- Loading branch information
Showing
1 changed file
with
5 additions
and
10 deletions.
There are no files selected for viewing
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -1,15 +1,10 @@ | ||
# Summary | ||
### Summary | ||
|
||
In this report, I will analyse a publicly available dataset based on clinical breast cancer data. Breast cancer is the most diagnosed cancer in women. There are several subtypes of diseases characterized by different genetic drivers for cancer risk | ||
and tumour growth. The human epidermal growth factor receptor 2 amplified (HER2: ERBB2 / ERBB2IP) breast cancer is one of the most aggressive subtypes. In addition, I will investigate HER3 (ERBB3), HER4 (ERBB4), PIK3C2B, MDM4, LRRN2, NFASC, KLHDC8A, and CDK18 gene mutations. Although there are targeted therapies that have been developed to treat these cancer cases, the response rate ranges from 40% - 50%. I will download, decompress, clean and process the TCGA | ||
RNASeq data for breast cancer from cbioportal and identify the differentially expressed genes between ERBB2 / ERBB2IP, ERBB3, ERBB4, PIK3C2B, MDM4, L | ||
RRN2, NFASC, KLHDC8A, and CDK18 cancer tumours. | ||
The dataset can be downloaded from this link: | ||
https://www.cbioportal.org/study/summary?id=brca_tcga_pan_can_atlas_2018. | ||
- In this report, I will analyse a publicly available dataset based on clinical breast cancer data. Breast cancer is the most diagnosed cancer in women. There are several subtypes of diseases characterized by different genetic drivers for cancer risk and tumour growth. The human epidermal growth factor receptor 2 amplified (HER2: ERBB2 / ERBB2IP) breast cancer is one of the most aggressive subtypes. In addition, I will investigate HER3 (ERBB3), HER4 (ERBB4), PIK3C2B, MDM4, LRRN2, NFASC, KLHDC8A, and CDK18 gene mutations. Although there are targeted therapies that have been developed to treat these cancer cases, the response rate ranges from 40% - 50%. I will download, decompress, clean and process the TCGA RNASeq data for breast cancer from cbioportal and identify the differentially expressed genes between ERBB2 / ERBB2IP, ERBB3, ERBB4, PIK3C2B, MDM4, LRRN2, NFASC, KLHDC8A, and CDK18 cancer tumours. | ||
- The dataset can be downloaded from this [link](https://www.cbioportal.org/study/summary?id=brca_tcga_pan_can_atlas_2018) | ||
|
||
### **Run All Code Chunks in _`assignment-2.qmd`_ from RStudio project** | ||
|
||
**Run All Code Chunks in _`assignment-2.qmd`_ from RStudio project** | ||
|
||
**Render PDF or HTML** | ||
#### **Render PDF or HTML** | ||
|
||
### See full report in html or pdf format at: [Full Report](https://conorheffron.github.io/gene-expr/assignment-2.html) |